Literature DB >> 11230622

Is breastfeeding really favoring early neonatal jaundice?

G Bertini1, C Dani, M Tronchin, F F Rubaltelli.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the development of significant hyperbilirubinemia in a large unselected newborn population in a metropolitan area with particular attention to the relationship between type of feeding and incidence of neonatal jaundice in the first week of life. STUDY
DESIGN: A population of 2174 infants with gestational age >/=37 weeks was prospectively investigated during the first days of life. Total serum bilirubin determinations were performed on infants with jaundice. The following variables were studied: type of feeding, method of delivery, weight loss after birth in relationship to the type of feeding, and maternal and neonatal risk factors for jaundice. Statistical analyses were performed using the z test for parametric variables and the t test for nonparametric variables. In addition, the multiple logistic regression allows for the estimation of the role of the individual characteristics in the development of hyperbilirubinemia. Data concerning serum bilirubin peak distribution in jaundiced newborns were analyzed using a single and a double Gaussian best fit at least squares. The t test was performed to compare 2 values (high and low) of the serum bilirubin peak in breastfed and supplementary-fed infants with those in bottle-fed infants.
RESULTS: The maximal serum bilirubin concentration exceeded 12.9 mg/dL (221 micromol/L) in 112 infants (5.1%). The study demonstrated a statistically significant positive correlation between patients with a total serum bilirubin concentration >12.9 mg/dL (221 micromol/L) and supplementary feeding; oppositely, breastfed neonates did not present a higher frequency of significant hyperbilirubinemia in the first days of life. However, best Gaussian fitting of our data suggests that a small subpopulation of breastfed infants have a higher serum bilirubin peak than do bottle-fed infants. Newborns with significant hyperbilirubinemia underwent a greater weight loss after birth compared with the overall studied population, and infants given mixed feeding lost more weight than breastfed and formula-fed newborns, indicating that formula has been administered in neonates who had a weight loss beyond a predetermined percentage of birth weight. Significant hyperbilirubinemia was also strongly associated with delivery by vacuum extractor, some perinatal complications (cephalohematoma, positive Coombs' test, and blood group systems of A, AB, B, and O [ABO] incompatibility) and Asian origin. Multiple logistic regression analysis shows that supplementary feeding, weight loss percentage, ABO incompatibility, and vacuum extraction significantly increase the risk of jaundice, while only cesarean section decreases the risk.
CONCLUSION: The present study confirms the important role of fasting in the pathogenesis of neonatal hyperbilirubinemia, although breastfeeding per se does not seem related to the increased frequency of neonatal jaundice but to the higher bilirubin level in a very small subpopulation of infants with jaundice. In fact, in the breastfed infants, there is a small subpopulation with higher serum bilirubin levels. These infants, when starved and/or dehydrated, could probably be at high risk of bilirubin encephalopathy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11230622     DOI: 10.1542/peds.107.3.e41

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  14 in total

1.  Transepidermal water loss and cerebral hemodynamics in preterm infants: conventional versus LED phototherapy.

Authors:  Giovanna Bertini; Silvia Perugi; Serena Elia; Simone Pratesi; Carlo Dani; Firmino F Rubaltelli
Journal:  Eur J Pediatr       Date:  2007-02-13       Impact factor: 3.183

2.  Hyperbilirubinemia in breastfed term neonates.

Authors:  Rashmi Ranjan Das
Journal:  Eur J Pediatr       Date:  2011-12-30       Impact factor: 3.183

3.  Risk factors for hyperbilirubinemia in breastfed term neonates.

Authors:  Ying-Juang Chen; Wei-Chuan Chen; Chung-Ming Chen
Journal:  Eur J Pediatr       Date:  2011-06-17       Impact factor: 3.183

4.  The impact of jaundice in newborn infants on the length of breastfeeding.

Authors:  Catherine M Pound; Isabelle Gaboury
Journal:  Paediatr Child Health       Date:  2009-09       Impact factor: 2.253

5.  Re: Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants (35 or more weeks' gestation) - Summary. Paediatr Child Health 2007;12(5):401-7.

Authors:  Jack Newman
Journal:  Paediatr Child Health       Date:  2007-09       Impact factor: 2.253

6.  Elevated bile acids in newborns with Biliary Atresia (BA).

Authors:  Kejun Zhou; Na Lin; Yongtao Xiao; Yang Wang; Jie Wen; Gang-Ming Zou; Xuefan Gu; Wei Cai
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

7.  An observational study of associations among maternal fluids during parturition, neonatal output, and breastfed newborn weight loss.

Authors:  Joy Noel-Weiss; A Kirsten Woodend; Wendy E Peterson; William Gibb; Dianne L Groll
Journal:  Int Breastfeed J       Date:  2011-08-15       Impact factor: 3.461

8.  Neonatal jaundice and stool production in breast- or formula-fed term infants.

Authors:  Hannah D Buiter; Sebastiaan S P Dijkstra; Rob F M Oude Elferink; Peter Bijster; Henk A Woltil; Henkjan J Verkade
Journal:  Eur J Pediatr       Date:  2007-07-10       Impact factor: 3.183

9.  Significant weight loss in breastfed term infants readmitted for hyperbilirubinemia.

Authors:  Ariel A Salas; Jorge Salazar; Claudia V Burgoa; Carlos A De-Villegas; Valeria Quevedo; Amed Soliz
Journal:  BMC Pediatr       Date:  2009-12-31       Impact factor: 2.125

10.  Factors affecting bilirubin levels during first 48 hours of life in healthy infants.

Authors:  Betul Siyah Bilgin; Ozge Altun Koroglu; Mehmet Yalaz; Semra Karaman; Nilgun Kultursay
Journal:  Biomed Res Int       Date:  2013-06-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.